Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO HEAL Pilot in Fragility Fractures
NCT06303284Phase 2Not yet recruiting
- Sponsor
- University of Calgary
- Start
- Mar 2027
- Primary completion
- Dec 2030
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of teriparatide in fragility fracture, sponsored by University of Calgary. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
teriparatide
03
Conditions
fragility fracture
Beyond the preview
Go deeper on NCT06303284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06303284.